Brief: Epigenomics H1 Net Loss Narrows To EUR 6.4 Million

Epigenomics AG

13/08/2020 07:04

Aug 13 (Reuters) - Epigenomics AG  ECXn.DE :
    * TOTAL REVENUE IN FIRST SIX MONTHS OF 2020 DECREASED BY 53%
TO
EUR 322 THOUSAND (6M 2019: EUR 679 THOUSAND)
    * ADJUSTED EBITDA (BEFORE SHARE-BASED PAYMENT EXPENSES) FOR
FIRST
SIX MONTHS OF 2020 WAS EUR -5.7 MILLION (6M 2019: EUR -7.2
MILLION).
    * NET LOSS FOR PERIOD IMPROVED TO EUR 6.4 MILLION (6M 2019:
EUR
7.4 MILLION)
    * PULLING ITS REVENUE GUIDANCE FOR 2020
    * MAINTAINS ITS PREVIOUS, ADJUSTED EBITDA (BEFORE
SHARE-BASED
PAYMENT EXPENSES) GUIDANCE OF BETWEEN EUR -10.5 MILLION TO EUR
-12.5 MILLION AND CASH CONSUMPTION GUIDANCE IN A RANGE OF EUR
10.5 MILLION TO EUR 12.5 MILLION

Source text for Eikon:  ID:nEQ6TnPZBa 
Further company coverage:  ECXn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))